Metamark Laboratory Services
Metamark is a pioneer in science with a mission to provide breakthrough diagnostic and prognostic solutions for urological cancer care.
The Metamark Solution
Metamark's comprehensive proprietary approach gives physicians and patients information they need to make better informed decisions.
Challenge: PSA Non-specificity
Metamark's molecular test information gives greater specificity than PSA testing alone.
Challenge: Biopsy Sampling Problem
Metamark's molecular tests can be more sensitive, as they are less prone to "geographic sampling error".
Challenge: Imprecise Monitoring and Prediction
Improved detection, specificity, and tumor behavior prediction is possible with Metamark's products.
Challenge: Poor Assessment of Tumor Aggressiveness
Metamark provides a personalized, individualized risk of aggressive disease.
Metamark is a pioneer in science with a mission to provide breakthrough diagnostic and prognostic solutions for urological cancer care.
No matter which test(s) you receive from our growing portfolio of advanced products and services, rest assured they are backed by our superior clinical expertise and the highest level of customer support.
ProMark®
ProMark is an advanced prognostic test developed specifically for prostate cancer. Following a prostate biopsy, ProMark uses automated image recognition technology to predict your risk of having an aggressive prostate cancer. You and your doctor can use your ProMark results to make a more informed and confident decision about your individual path of treatment.
Progensa® PCA3
Progensa PCA3 is a very sensitive, gene-based urine test providing additional, valuable information to you and your doctor to help you decide if a repeat prostate biopsy is necessary.
Cytology
Our cytology diagnostic services provide superior specificity in the diagnosis of bladder cancer. Metamark pathologists thoroughly examine your urine sample to evaluate for cancer cells or other abnormalities.
FISH
Fluorescence in situ hybridization (FISH) is a diagnostic tool that may help confirm your cytology results, monitor bladder cancer recurrence, and measure treatment response. FISH can identify genetic changes at the chromosomal level, before cancer is visible.
Histology
Our histology diagnostic services include expert prostate and bladder biopsy analysis as well as supporting services and examinations.
PTEN/ERG
PTEN/ERG molecular testing predicts the aggressiveness of your prostate cancer after your prostate biopsy analysis. Depending on your biopsy results, PTEN/ERG may be the right choice to provide additional information helping you and your doctor to learn more about your specific prostate cancer and determine the best path of treatment.